INCLUDING a pharmacy's Chemotherapy Compounder ID will be mandatory within PBS claims from 01 Dec 2017, according to a Health Department update.
All approved pharmacists, approved medical practitioners and approved public and private hospital authorities will need to comply with the change.
Compounder IDs are available from the Chemotherapy Compounding Payment Scheme (CCPS) Administration Agency, Australian Healthcare Associates - see pbs.gov.au for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Nov 17